Ciloa will be at BIO Europe in Vienna on November 4-6, 2013.
Dr Robert Mamoun will present Ciloa technology on November 5th at 9.10 am.
Ciloa technology allows getting each kind of fully native and mature membrane proteins out of cells on small vesicles called exosomes. The proteins belong to all classes: GPCRs, Kinase Receptors, Ion channels, viral proteins, Ig superfamily, etc.
With this innovation, new drugs against membrane proteins receptors, therapeutic monoclonal antibodies, vaccines are developed. This technology is also helpfull in the development of tools for clinical diagnostic.
The applications concern all the domains of human health (cancers, cardiopathologies, diabetes, neuro-pathologies, infectious diseases…).